ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

The Dallas Morning News Launches Transformative Series Examining Fentanyl’s Deadly Grip on North Texas

30 straight days of comprehensive coverage during September
Unflinching look at the scope and scale of damage to schools, families, communities

DALLAS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) -

This September, The Dallas Morning News is investigating and detailing the burgeoning fentanyl epidemic, known as the deadliest drug threat in American history. The potent synthetic opioid has been responsible for the overdose deaths of over 1,100 North Texans since 2021.

More than two dozen News staffers spent months researching, reporting, writing, editing, photographing and designing a wide-ranging package about the deadly drug. “Deadly Fake: 30 Days Inside Fentanyl’s Grip on North Texas,” tells in heart-breaking and stark detail the rapidly growing crisis unfolding across the nation and at home.

“Thirty days of a single topic is a significant undertaking for any publication. But this is an urgent problem, and with no clear answers, it’s incumbent on us to bring a new understanding of how hazardous this drug is,” said Katrice Hardy, The News’s executive editor. “This is where news organizations excel – telling the truth, providing context and conveying solutions as we know them.”

The series introduces readers to those affected by the most potent, addictive, disguisable drug ever created and how it got to North Texas. Meet families who have lost their children. Learn about fentanyl’s swift and dangerous effects on the human body – from as little as 2 milligrams, about the same as 10 to 15 grains of table salt. This makes it 50 times more potent than a lethal dose of heroin and 100 times more powerful than morphine. Understand how law enforcement and health care are learning to handle an epidemic again.

Yet, there is hope. The power of knowledge and awareness has the potential to mitigate the relentless spread of this mounting and insidious problem and stop the trend of five Texans dying from it every day.

Join us.

Fentanyl Tools and Resources

Dallas Morning News Resources
Series home: dallasnews.com/deadlyfake
Instagram: @dallasnews
Facebook: @dallasmorningnews
Twitter: @dallasnews
TikTok: @dallasmorningnews
YouTube: @dallasnews

DallasNews Corporation is the Dallas-based holding company of The Dallas Morning News and Medium Giant. The Dallas Morning News is Texas’ leading daily newspaper with a strong journalistic reputation, intense regional focus and close community ties. Medium Giant is a media and marketing agency of divergent thinkers who devise strategies that deepen connections, expand influence, and scale success for clients nationwide. For additional information, visit dallasnewscorporation.com or email invest@dallasnews.com

Contact:
Katrice Hardy, executive editor, The Dallas Morning News
katrice.hardy@dallasnews.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.